Geoprocessamento como Ferramenta de Análise de Possíveis Grandes Geradores de Resíduos Sólidos

Em 2010, o Governo Federal criou a Política Nacional de Resíduos Sólidos (PNRS), Lei 12.305/2010 (Brasil, 2010a), a respeito da gestão e do gerenciamento adequado dos resíduos sólidos no Brasil. Em 2012, o Município de Campo Grande, Estado de Mato Grosso do Sul, criou a Lei Complementar 209/2012 (Campo Grande, 2012), que instituiu o Código Municipal de Resíduos Sólidos e tratou da limpeza urbana e de diretrizes sobre o gerenciamento de seus resíduos sólidos. A Lei Complementar definiu o que são Grandes Geradores de Resíduos Sólidos determinou suas responsabilidades, sendo, então, necessária a identificação desses locais. O presente trabalho utilizou de ferramentas de geoprocessamento para identificação e análise desses locais. Foram obtidos o mapa de densidade de possíveis Grandes Geradores e mapas de intensidade de resíduos gerados através de dois diferentes interpoladores, que foram comparados com uma lista tabelada do Índice de Qualidade de Vida (IQV) de cada bairro do município. A utilização do geoprocessamento mostrou-se eficiente, sendo possível identificar os prováveis locais dos Grandes Geradores. Também foi possível observar que esses locais coincidiram com bairros com altos valores de IQV. Assim, o poder público pode fazer uso dessa ferramenta para identificar, monitorar e fiscalizar esse tipo de estabelecimento

ATIVIDADE DO NEONICOTINOIDE TIAMETOXAM SOBRE Musca domestica (LINNAEUS, 1758) (DIPTERA, MUSCIDAE)

A partir de ensaios in vitro, em ambiente controlado e a campo, foi avaliada a atividade do inseticida tiametoxam em populações de Musca domestica provenientes da colônia do Laboratório de Doenças Parasitárias do Departamento de Epidemiologia e Saúde Pública da Universidade Federal Rural do Rio de Janeiro e do aterro sanitário do Município de Seropédica, RJ. Para a técnica in vitro o ativo utilizado foi previamente diluído em acetona, obtendo-se as concentrações de 5; 7,5; 10; 12,5; 15; 17,5; 20; 22,5; 25; 27,5 e 30 mg/ml. Em seguida, discos de papel-filtro foram impregnados com 1 ml de cada uma dessas diluições e realizaram-se testes com estas em moscas adultas acondicionadas em placas de Petri, sendo que os discos do grupo-controle foram impregnados apenas com acetona. Para técnica em ambiente controlado e em nível de campo, empregaram-se iscas com o ativo e placebo para o grupo-controle. O valor calculado da dose letal 50 (DL50), utilizando-se a técnica in vitro, para tiametoxam em M. domestica foi de 0,2612 mg/cm². A eficácia das iscas com tiamethoxan no ensaio em ambiente controlado e em nível de campo foi de 94,06 % e 98,09 %, respectivamente. PALAVRAS-CHAVES: Iscas, Musca domestica, neonicotinoides, tiametoxa

Proposta de Sequência Didática para o Ensino de Funções de Duas Variáveis Utilizando o Geogebra Mobile/ Proposal of Didactic Sequence for Teaching of Functions of Two Variables Using Mobile Geogebra

As funções de várias variáveis são aplicadas em diversos problemas da matemática e de outras áreas e por essa razão, seu entendimento é fundamental para a progressão a outros conteúdos. Diante disso, propõe-se uma sequência didática para o ensino de funções de duas variáveis em que o GeoGebra é utilizado na versão mobile. Nesta sequência, os conteúdos de domínio, imagem e curvas de nível são apresentados de forma algébrica e geométrica com o auxílio do gráfico da função que é plotado no aplicativo. O roteiro apresentado ilustra um exemplo detalhando todas as fases e interações feita no aplicativo, mostrando que o GeoGebra é uma ferramenta didática que pode contribuir na visualização e compreensão dos conceitos de funções

MAMMALS IN PORTUGAL : A data set of terrestrial, volant, and marine mammal occurrences in P ortugal

Mammals are threatened worldwide, with 26% of all species being includedin the IUCN threatened categories. This overall pattern is primarily associatedwith habitat loss or degradation, and human persecution for terrestrial mam-mals, and pollution, open net fishing, climate change, and prey depletion formarine mammals. Mammals play a key role in maintaining ecosystems func-tionality and resilience, and therefore information on their distribution is cru-cial to delineate and support conservation actions. MAMMALS INPORTUGAL is a publicly available data set compiling unpublishedgeoreferenced occurrence records of 92 terrestrial, volant, and marine mam-mals in mainland Portugal and archipelagos of the Azores and Madeira thatincludes 105,026 data entries between 1873 and 2021 (72% of the data occur-ring in 2000 and 2021). The methods used to collect the data were: live obser-vations/captures (43%), sign surveys (35%), camera trapping (16%),bioacoustics surveys (4%) and radiotracking, and inquiries that represent lessthan 1% of the records. The data set includes 13 types of records: (1) burrowsjsoil moundsjtunnel, (2) capture, (3) colony, (4) dead animaljhairjskullsjjaws, (5) genetic confirmation, (6) inquiries, (7) observation of live animal (8),observation in shelters, (9) photo trappingjvideo, (10) predators dietjpelletsjpine cones/nuts, (11) scatjtrackjditch, (12) telemetry and (13) vocalizationjecholocation. The spatial uncertainty of most records ranges between 0 and100 m (76%). Rodentia (n=31,573) has the highest number of records followedby Chiroptera (n=18,857), Carnivora (n=18,594), Lagomorpha (n=17,496),Cetartiodactyla (n=11,568) and Eulipotyphla (n=7008). The data setincludes records of species classified by the IUCN as threatened(e.g.,Oryctolagus cuniculus[n=12,159],Monachus monachus[n=1,512],andLynx pardinus[n=197]). We believe that this data set may stimulate thepublication of other European countries data sets that would certainly contrib-ute to ecology and conservation-related research, and therefore assisting onthe development of more accurate and tailored conservation managementstrategies for each species. There are no copyright restrictions; please cite thisdata paper when the data are used in publications.info:eu-repo/semantics/publishedVersio

Impact of COVID-19 Pandemic on TAVR Activity: A Worldwide Registry

Background: The COVID-19 pandemic had a considerable impact on the provision of structural heart intervention worldwide. Our objectives were: 1) to assess the impact of the COVID-19 pandemic on transcatheter aortic valve replacement (TAVR) activity globally; and 2) to determine the differences in the impact according to geographic region and the demographic, development, and economic status of diverse international health care systems. Methods: We developed a multinational registry of global TAVR activity and invited individual TAVR sites to submit TAVR implant data before and during the COVID-19 pandemic. Specifically, the number of TAVR procedures performed monthly from January 2019 to December 2021 was collected. The adaptive measures to maintain TAVR activity by each site were recorded, as was a variety of indices relating to type of health care system and national economic indices. The primary subject of interest was the impact on TAVR activity during each of the pandemic waves (2020 and 2021) compared with the same period pre–COVID-19 (2019). Results: Data were received from 130 centers from 61 countries, with 14 subcontinents and 5 continents participating in the study. Overall, TAVR activity increased by 16.7% (2,337 procedures) between 2018 and 2019 (ie, before the pandemic), but between 2019 and 2020 (ie, first year of the pandemic), there was no significant growth (–0.1%; –10 procedures). In contrast, activity again increased by 18.9% (3,085 procedures) between 2020 and 2021 (ie, second year of the pandemic). During the first pandemic wave, there was a reduction of 18.9% (945 procedures) in TAVR activity among participating sites, while during the second and third waves, there was an increase of 6.7% (489 procedures) and 15.9% (1,042 procedures), respectively. Further analysis and results of this study are ongoing and will be available at the time of the congress. Conclusion: The COVID-19 pandemic initially led to a reduction in the number of patients undergoing TAVR worldwide, although health care systems subsequently adapted, and the number of TAVR recipients continued to grow in subsequent COVID-19 pandemic waves. Categories: STRUCTURAL: Valvular Disease: Aorti

The ARIA-MASK-air® approach

Funding Information: The authors thank Ms Véronique Pretschner for submitting the paper. MASK‐air has been supported by Charité Universitätsmedizin Berlin, EU grants (EU Structural and Development Funds Languedoc Roussillon and Region PACA; POLLAR: EIT Health; Twinning: EIP on AHA; Twinning DHE: H2020; Catalyse: Horizon Europe) and educational grants from Mylan‐Viatris, ALK, GSK, Novartis, Stallergènes‐Greer and Uriach. None for the study. ® Publisher Copyright: © 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.MASK-air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air® is a Good Practice of DG Santé on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air® data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air® data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air® results should lead to change management in rhinitis and asthma.publishersversionpublishe

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.

Background: The evidence base regarding the safety of intravenous (IV) iron therapy in patients with chronic kidney disease (CKD) is incomplete and largely based on small studies of relatively short duration. Methods: FIND-CKD (ClinicalTrials.gov number NCT00994318) was a 1-year, open-label, multicenter, prospective study of patients with nondialysis-dependent CKD, anemia and iron deficiency randomized (1:1:2) to IV ferric carboxymaltose (FCM), targeting higher (400-600 µg/L) or lower (100-200 µg/L) ferritin, or oral iron. A post hoc analysis of adverse event rates per 100 patient-years was performed to assess the safety of FCM versus oral iron over an extended period. Results: The safety population included 616 patients. The incidence of one or more adverse events was 91.0, 100.0 and 105.0 per 100 patient-years in the high ferritin FCM, low ferritin FCM and oral iron groups, respectively. The incidence of adverse events with a suspected relation to study drug was 15.9, 17.8 and 36.7 per 100 patient-years in the three groups; for serious adverse events, the incidence was 28.2, 27.9 and 24.3 per 100 patient-years. The incidence of cardiac disorders and infections was similar between groups. At least one ferritin level ≥800 µg/L occurred in 26.6% of high ferritin FCM patients, with no associated increase in adverse events. No patient with ferritin ≥800 µg/L discontinued the study drug due to adverse events. Estimated glomerular filtration rate remained the stable in all groups. Conclusions: These results further support the conclusion that correction of iron deficiency anemia with IV FCM is safe in patients with nondialysis-dependent CKD

Measurement of differential cross sections for top quark pair production using the lepton plus jets final state in proton-proton collisions at 13 TeV

National Science Foundation (U.S.